Andro, DHEA Sales Restriction Suggested As Topic For Senate Hearing
This article was originally published in The Tan Sheet
Executive Summary
Limitations on the sale of androstenedione and dehydroepiandrosterone (DHEA) was suggested as the topic for a future hearing by members of the Senate Commerce/Consumer Affairs Subcommittee at a June 18 meeting of the panel